Brief: Star Combo Pharma Announces Q1 FY 22 Business Update
Nov 23 (Reuters) - Star Combo Pharma Ltd S66.AX :
* S66 - Q1 FY 22 BUSINESS UPDATE
* Q1 FY22 REVENUE OF A$5.8M
* FY22 OUTLOOK POSITIVE FOR OEM UNIT WITH STRONG
MANUFACTURING
ORDER BOOK IN PLACE
Source text for Eikon: ID:nASX8j7840
Further company coverage: S66.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Star Combo Pharma
See all newsBrief: Star Combo Pharma Announces Insurance Claim Settlement Of A$5 Million
Brief: Star Combo Pharma Says Outlook For FY2025 Is Positive
Brief: Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
Brief: Star Combo Pharma Posts Q1 Fy23 Revenue Of A$6.55M
Australia's Star Combo Pharma plunges to record low on fire incident